The availability of wide range of medicines (Drugs) in every conceivable therapeutic category has revolutionized the practice of therapeutics over the past few decades. Drugs are also now being widely used for diagnostic and prophylactic purposes. Adverse Drud Reactions are being detected more and more. To make the drug therapy safer and new drug also made safer, a Pharmaco Vigilance Committee has been constituted as a part of India’s Nationl Phamacovigilence Programme (NAVP-India).
Name | Designation | Role |
Prof. (Dr.) Manimoy Bandyopadhyay | Director, IPGME&R | Chairman |
Prof. (Dr.) Pijush Kumar Roy | MSVP, SSKM Hospital | Member |
Prof. (Dr.) Avijit Hazra | Dean of Student Affairs, IPGME&R | Member |
Prof. (Dr.) Amal Kanti Das | Ex-Dean & Member of Academic Council | Member |
Prof. (Dr.) Amit Kr. Bhattacharyya | Director, IOP & HOD, Psychiatry, IPGME&R | Member |
Prof. (Dr.) Soumitra Ghosh | HOD, Dept. of General Medicine, IPGME&R | Member |
Prof. (Dr.) Alakendu Ghosh | HOD, Dept. of Rheumatology, IPGME&R | Member (NGO Representative) |
Prof. (Dr.) Suchandra Mukherjee | HOD, Dept. of Neonatology, IPGME&R | Member |
Prof. (Dr.) Subhash Ch. Biswas | Dept. of Obst. & Gynae, IPGME&R | Member |
Prof. (Dr.) Suparna Chatterjee | Dept. of Pharmacology, IPGME&R | Convenor |
Prof. (Dr.) Diptendra Kumar Sarkar | Dept. of Surgery, IPGME&R | Member |